CIDRAP news story
16 January 2025 — A $1.6 million vaccine study in the small West African nation of Guinea-Bissau — announced by the Centers for Disease Control and Prevention last month — has caused concerns and confusion from the very beginning.
Although the World Health Organization advises giving a birth dose of hepatitis B vaccine to prevent infants from being infected during delivery, researchers leading the new study plan to randomly assign only half of the 14,000 newborns in the clinical trial to receive it.
Now, the controversial study — scheduled to begin this month — may be canceled.
At a Thursday briefing of the Africa Centres for Disease Control and Prevention, an official told reporters that the study won’t take place as planned.
That news surprised officials at the Department of Health and Human Services (HHS).
“It is not our view that the study has been canceled,” said an official at HHS not permitted to speak on the record.
Read the full news story here.
SEE ALSO:
- Health Policy Watch: Confusion over ‘cancellation’ of controversial hepatitis B trial in Guinea-Bissau /16 January 2025/
- The Guardian: Controversial US study on hepatitis B vaccines in Africa is cancelled /15 January 2025/
Source : CIDRAP
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.